Dental Safety Profile of High-Dose Radioiodine Therapy

The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.

NCT04447183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

NCT04971473 ·Status: COMPLETED ·Phase: PHASE3

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

NCT04354324 ·Status: RECRUITING ·Phase: NA

High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer

NCT00415233 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

NCT04137185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Iodinated Contrast Media Induced Hyperthyroidism

NCT04304794 ·Status: COMPLETED

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients

NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

NCT00439127 ·Status: COMPLETED

Multicenter Study Differentiated Thyroid Carcinoma

NCT00144079 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

NCT00926978 ·Status: TERMINATED ·Phase: NA

Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer

NCT00604318 ·Status: COMPLETED ·Phase: PHASE4

Thyroid Cancer in United Arab Emirates

NCT04763122 ·Status: COMPLETED

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

NCT00115895 ·Status: UNKNOWN ·Phase: PHASE3

Effects of Radioactive Iodine on the Immune System in Thyroid Cancer

NCT05989555 ·Status: NOT_YET_RECRUITING

Effect of Childhood Radioiodine Therapy on Salivary Function

NCT02375451 ·Status: COMPLETED

rhTSH-Thyroid Ablation With 1850 MBq of 131I

NCT00454077 ·Status: COMPLETED

Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer

NCT02706743 ·Status: UNKNOWN

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

NCT04964284 ·Status: RECRUITING ·Phase: PHASE3

Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer

NCT01744769 ·Status: UNKNOWN

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

NCT03841617 ·Status: RECRUITING ·Phase: PHASE2

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients

NCT05316922 ·Status: RECRUITING ·Phase: PHASE3

Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

NCT00360074 ·Status: COMPLETED ·Phase: PHASE4

Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine

NCT02773667 ·Status: COMPLETED

Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

NCT00749697 ·Status: UNKNOWN ·Phase: NA

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3